Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
Open Access
- 11 May 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8633
Abstract
The papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a critical role in the proteolytic processing of viral polyproteins and the dysregulation of the host immune response, providing a promising therapeutic target. Here, we report the structure-guide design of novel peptidomimetic inhibitors covalently targeting SARS-CoV-2 PLpro. The resulting inhibitors demonstrate submicromolar potency in the enzymatic assay (IC50 = 0.23 μM) and significant inhibition of SARS-CoV-2 PLpro in the HEK293T cells using a cell-based protease assay (EC50 = 3.61 μM). Moreover, an X-ray crystal structure of SARS-CoV-2 PLpro in complex with compound 2 confirms the covalent binding of the inhibitor to the catalytic residue cysteine 111 (C111) and emphasizes the importance of interactions with tyrosine 268 (Y268). Together, our findings reveal a new scaffold of SARS-CoV-2 PLpro inhibitors and provide an attractive starting point for further optimization.Keywords
Funding Information
- National Natural Science Foundation of China (22277130, LG-QS-202205-02, 20430780300)
- Lingang Laboratory (22277130, LG-QS-202205-02, 20430780300)
- Science and Technology Commission of Shanghai Municipality (22277130, LG-QS-202205-02, 20430780300)
This publication has 36 references indexed in Scilit:
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunityNature, 2020
- Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like ProteaseACS Infectious Diseases, 2020
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceScience Translational Medicine, 2020
- Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical BiologyJournal of Medicinal Chemistry, 2018
- Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like ProteaseMolecular Cell, 2016
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D Structural Biology, 2011
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replicationProceedings of the National Academy of Sciences, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- The Papain-Like Protease from the Severe Acute Respiratory Syndrome Coronavirus Is a Deubiquitinating EnzymeJournal of Virology, 2005
- PHENIX: building new software for automated crystallographic structure determinationActa Crystallographica Section D Structural Biology, 2002